Tandem Diabetes Care Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,007	940.2	747.72	801.22	702.8	498.83
Revenue Growth (YoY)	17.87%	25.74%	-6.68%	14.00%	40.89%	37.68%
Cost of Revenue	470.99	450.63	380.03	388.23	326.58	238.31
Gross Profit	536.01	489.57	367.69	412.99	376.22	260.52
Selling, General & Admin	426.87	389.82	338.4	335.68	261.51	204.9
Research & Development	196.14	198.88	169.67	139.11	92.05	63.57
Operating Expenses	623.01	588.7	508.07	474.8	353.56	268.48
Operating Income	-87	-99.13	-140.38	-61.81	22.65	-7.96
Interest Expense	-7.69	-7.42	-9.88	-6.21	-6.04	-12.81
Interest & Investment Income	16.5	22.1	21.2	6.06	0.67	1.57
Earnings From Equity Investments	-11.69	-2.05	-	-	-	-
Currency Exchange Gain (Loss)	-7	-2	1.5	-	-	-
Other Non Operating Income (Expenses)	3.08	-0.11	0.16	0.15	-1.39	-17.09
EBT Excluding Unusual Items	-93.8	-88.6	-127.4	-61.81	15.9	-36.28
Gain (Loss) on Sale of Investments	-2	-2	-	-	-	-
Asset Writedown	-6.7	-	-14.1	-	-	-
Other Unusual Items	-	-1.27	-	-	-	-
Pretax Income	-204.94	-91.87	-220.25	-92.85	15.9	-36.28
Income Tax Expense	-1.57	4.16	2.36	1.74	0.34	-1.9
Net Income	-203.37	-96.03	-222.61	-94.59	15.57	-34.38
Net Income to Common	-203.37	-96.03	-222.61	-94.59	15.57	-34.38
Shares Outstanding (Basic)	67	65	65	64	63	61
Shares Outstanding (Diluted)	67	65	65	64	64	61
Shares Change (YoY)	2.23%	0.74%	1.28%	-0.32%	5.51%	4.24%
EPS (Basic)	-3.05	-1.47	-3.43	-1.47	0.25	-0.56
EPS (Diluted)	-3.05	-1.47	-3.43	-1.47	0.24	-0.56
Free Cash Flow	-25.13	4.99	-58.61	16.37	97.18	-2.74
Free Cash Flow Per Share	-0.38	0.08	-0.90	0.26	1.51	-0.04
Gross Margin	53.23%	52.07%	49.18%	51.54%	53.53%	52.23%
Operating Margin	-8.64%	-10.54%	-18.77%	-7.71%	3.22%	-1.59%
Profit Margin	-20.20%	-10.21%	-29.77%	-11.81%	2.21%	-6.89%
Free Cash Flow Margin	-2.50%	0.53%	-7.84%	2.04%	13.83%	-0.55%
EBITDA	-69.58	-82.52	-124.67	-47.48	36.5	2.49
EBITDA Margin	-6.91%	-8.78%	-16.67%	-5.93%	5.19%	0.50%
D&A For EBITDA	17.42	16.61	15.72	14.33	13.85	10.45
EBIT	-87	-99.13	-140.38	-61.81	22.65	-7.96
EBIT Margin	-8.64%	-10.54%	-18.77%	-7.71%	3.22%	-1.59%
Effective Tax Rate	-	-	-	-	2.11%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q